Page last updated: 2024-10-19

phenylacetic acid and Central Nervous System Neoplasm

phenylacetic acid has been researched along with Central Nervous System Neoplasm in 1 studies

phenylacetic acid : A monocarboxylic acid that is toluene in which one of the hydrogens of the methyl group has been replaced by a carboxy group.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Berg, S1
Serabe, B1
Aleksic, A1
Bomgaars, L1
McGuffey, L1
Dauser, R1
Durfee, J1
Nuchtern, J1
Blaney, S1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy[NCT04937062]Early Phase 150 participants (Anticipated)Interventional2021-03-01Enrolling by invitation
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for phenylacetic acid and Central Nervous System Neoplasm

ArticleYear
Pharmacokinetics and cerebrospinal fluid penetration of phenylacetate and phenylbutyrate in the nonhuman primate.
    Cancer chemotherapy and pharmacology, 2001, Volume: 47, Issue:5

    Topics: Animals; Antimetabolites, Antineoplastic; Area Under Curve; Central Nervous System Neoplasms; Chroma

2001